The state of public research on over-the-counter drug advertising

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 4, Issue 3, 2010, Pages 208-231

  Delorme, Denise E ^a   Huh, Jisu ^b   Reid, Leonard N ^c   An, Soontae ^d  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

Advertising; Drugs; Pharmaceuticals industry

Indexed keywords

EID: 77956534343     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506121011076156     Document Type: Review

References (87)

1. Almarsdottir, A.B. and Bush, P.J. (1992), “The influence of drug advertising on children's drug use attitudes and behaviors”, Journal of Drug Issues, Vol. 22, Spring, pp. 361-76.
2. Applebaum, M. (2008), “For OTC, things are just A-OK”, Brandweek, Vol. 16, June, p. S043.
3. Atkin, C.K. (1978), “Effects of drug commercials on young viewers”, Journal of Communication, Vol. 28, Autumn, pp. 71-9.
4. Auton, F. (2004), “The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate”, International Journal of Advertising, Vol. 23 No. 1, pp. 5-52.
5. Baker, S.M., Gentry, J.W. and Rittenburg, T.L. (2005), “Building understanding of the domain of consumer vulnerability”, Journal of Macromarketing, Vol. 25 No. 2, pp. 128-39.
6. Berry, T.M. (2001), Nursing Nonprescription Drug Handbook, Lippincott Williams & Wilkins, Philadelphia, PA.
7. Bienkinsopp, A. and Bradley, C. (1996), “Over the counter drugs: patients, society, and the increase in self-medication”, British Medical Journal, Vol. 312, March, pp. 629-32.
8. Brenkert, G.G. (1998), “Marketing and the vulnerable”, Business Ethics Quarterly, No. 1, pp. 7-20 (special issue).
9. Brownfield, E.D., Bernhardt, J.M., Phan, J.L., Williams, M.V. and Parker, R.M. (2004), “Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement”, Journal of Health Communication, Vol. 9 No. 6, pp. 491-7.
10. Butter, E.J., Weikel, K.B., Otto, V., Wright, K.P. and Deinzer, G. (1991), “TV advertising of OTC medicines and its effects on child viewers”, Psychology & Marketing, Vol. 8, Summer, pp. 117-28.
11. Byrd-Bredbenner, C. and Grasso, D. (1999), “Prime-time health: an analysis of health content in television commercials broadcast during programs viewed heavily by children”, International Electronic Journal of Health Education, Vol. 2 No. 4, pp. 159-69.
12. Calfee, J.E. (2002), “Public policy issues in direct-to-consumer advertising of prescription drugs”, Journal of Public Policy & Marketing, Vol. 21 No. 2, pp. 174-93.
13. Chandra, A. and Holt, G.A. (1999), “Pharmaceutical advertisements: how they deceive patients”, Journal of Business Ethics, Vol. 18 No. 4, pp. 359-66.
14. Choi, S.M. and Lee, W. (2007), “Understanding the impact of direct-to-consumer (DTC) pharmaceutical advertising on patient-physician interactions: adding the web to the mix”, Journal of Advertising, Vol. 36 No. 3, pp. 137-49.
15. Consumer Healthcare Products Association (2009), “OTC retail sales 1964-2008”, available at: www.chpa-info.org/pressroom/Retail_Sales.aspx (accessed 19 June 2009).
16. Covington, T.R. (2006), “Nonprescription drug therapy: issues and opportunities”, American Journal of Pharmaceutical Education, Vol. 70 No. 6, pp. 1-5.
17. Creyer, E.H., Hrsistodoulakis, I. and Cole, C.A. (2001), “Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs”, Journal of Product & Brand Management, Vol. 10 No. 1, pp. 52-64.
18. DeLorme, D.E., Huh, J. and Reid, L.N. (2006), “Perceived effects of DTC prescription drug advertising on self and others: a third person effects study of older consumers”, Journal of Advertising, Vol. 35 No. 3, pp. 47-65.
19. Diehl, S., Mueller, B. and Terlutter, R. (2007), “Skepticism toward pharmaceutical advertising in US and Germany”, Advances in International Marketing, Vol. 18, pp. 31-60.
20. Diehl, S., Mueller, B. and Terlutter, R. (2008), “Consumer responses towards non-prescription and prescription drug advertising in the US and Germany”, International Journal of Advertising, Vol. 27 No. 1, pp. 99-131.
21. Donohue, J. (2006), “A history of drug advertising: the evolving roles of consumers and consumer protection”, The Milbank Quarterly, Vol. 84 No. 4, pp. 659-99.
22. Drug Week (2009), “Allergies: private-label OTC drugs post solid gains in 2008, according to Kline”, Drug Week, 24 April.
23. Federal Trade Commission (2001), “Frequently asked advertising questions: a guide for small business – general advertising policies”, available at: http://ftc.gov/bcp/edu/pubs/business/adv/bus35.shtm (accessed 26 April 2010).
24. Federal Trade Commission (2004), A guide to the Federal Trade Commission, available at: www.ftc.gov/bcp/edu/pubs/consumer/general/gen03.shtm (accessed 26 April 2010).
25. Federal Trade Commission (2009), “FTC prescription drugs and over-the-counter (OTC) drugs: questions and answers”, available at: www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm100101.htm (accessed 26 April 2010).
26. Federal Trade Commission (2010a), “Legal resources – statutes relating to both missions”, available at: www.ftc.gov/ogc/stat1.shtm (accessed 26 April 2010).
27. Federal Trade Commission (2010b), “Office of nonprescription drug products: what we do”, available at: www.fda.gov/AboutFDA/CentersOffices/CDER/ucm106342.htm (accessed 26 April 2010).
28. Federal Trade Commission (2010c), “Regulation of nonprescription drug products”, Federal Trade Commission, available at: www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM148055.pdf (accessed 02 June 2010).
29. Francis, S., Barnett, N. and Denham, M. (2005), “Switching of prescription drugs to over-the-counter status”, Drugs and Aging, Vol. 22 No. 5, pp. 361-70.
30. Gardner, D.M. (1975), “Deception in advertising: a conceptual approach”, Journal of Marketing, Vol. 39 No. 2, pp. 40-6.
31. Garrett, D. and Toumanoff, P.G. (2010), “Are consumers disadvantaged or vulnerable? An examination of consumer complaints to the better business bureau”, Journal of Consumer Affairs, Vol. 44 No. 1, pp. 3-23.
32. Gentry, J.W., Kennedy, P.F., Paul, K. and Hill, R.P. (1994), “The vulnerability of those grieving the death of a loved one: implications for public policy”, Journal of Public Policy & Marketing, Vol. 13 No. 2, pp. 128-42.
33. Gerbner, G., Gross, L., Morgan, M. and Signorelli, N. (1986), “Living with television: the dynamics of the cultivation process”, in Bryant, J. and Zillman, D. (Eds), Perspectives on Media Effects, Lawrence Erlbaum, Hillsdale, NJ, pp. 17-40.
34. Gunther, A.C. and Storey, J.D. (2003), “The influence of presumed influence”, Journal of Communication, Vol. 53 No. 2, pp. 199-214.
35. Hoek, J., Gendall, P. and Calfee, J. (2004), “Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses”, International Journal of Advertising, Vol. 23 No. 2, pp. 197-227.
36. Hoog, S. (1994), “Over-the-counter drug advertising: argumentation or persuasion?”, Journal of Pharmaceutical Marketing and Management, Vol. 9 No. 2, pp. 69-91.
37. Howland, R.H. (2008), “How are drugs approved? Part 1: the evolution of the food and drug administration”, Journal of Psychosocial Nursing & Mental Health Services, Vol. 46 No. 1, pp. 15-19.
38. Hoy, M.G. (1994), “Switch drugs vis-à-vis Rx and OTC: policy, marketing, and research considerations”, Journal of Public Policy & Marketing, Vol. 13 No. 1, pp. 85-96.
39. Huh, J. and Cude, B.J. (2004), “Is the information ‘fair and balanced’ in direct-to-consumer prescription drug websites?”, Journal of Health Communication, Vol. 9 No. 6, pp. 1-12.
40. Huh, J., DeLorme, D.E. and Reid, L.N. (2004), “The third-person effect and its influence on behavioral outcomes in a product advertising context: the case of direct-to-consumer prescription drug advertising”, Communication Research, Vol. 31 No. 5, pp. 1-32.
41. Huh, J., DeLorme, D.E. and Reid, L.N. (2005), “Factors affecting trust in online prescription drug information and impact of trust on behavior following exposure to DTC advertising”, Journal of Health Communication, Vol. 10 No. 8, pp. 711-31.
42. Hulbert, J. (1975), “Applying buyer behavior analysis to social problems: the case of drug use”, Combined Proceedings of the American Marketing Association, Chicago, IL, pp. 289-92.
43. IBISWorld Industry Reports (2009), “Pharmaceutical and medicine manufacturing in the US 32541”, IBISWorld Industry Report, New York, NY.
44. Kavanoor, S., Grewal, D. and Blodgett, J. (1997), “Ads promoting OTC medications: the effect of ad format and credibility on beliefs, attitudes, and purchase intentions”, Journal of Business Research, Vol. 40 No. 3, pp. 219-27.
45. Kim, J.W. and King, K.W. (2009), “Product category effects on external search for prescription and nonprescription drugs”, Journal of Advertising, Vol. 38 No. 1, pp. 5-19.
46. Kittinger, P. and Herrick, D. (2005), “Patient power: over-the-counter drugs”, National Center for Policy Analysis, Brief Analysis, Vol. 524, August, pp. 1-2.
47. Kline, K.N. (2006), “A decade of research on health content in the media: the focus on health challenges and sociocultural context and attendant informational and ideological problems”, Journal of Health Communication, Vol. 11 No. 1, pp. 43-59.
48. Koch, Y.D., Ernst, M.E. and Kelly, M.W. (2002), “Patient perceptions about drug advertising and prescription-to-nonprescription switches”, American Journal of Health-System Pharmacy, Vol. 59 No. 16, p. 1568.
49. Ling, D.C., Berndt, E.R. and Kyle, M.K. (2002), “Regulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter product sales”, Journal of Law & Economics, Vol. 45, October, pp. 691-723.
50. Lowe, N.K. and Ryan-Wenger, N.M. (1999), “Over-the-counter medicines and self-care”, The Nurse Practitioner, Vol. 24, December, pp. 34-44.
51. Macias, W. and Lewis, L.S. (2003), “A content analysis of direct-to-consumer (DTC) prescription drug web sites”, Journal of Advertising, Vol. 32 No. 4, pp. 43-56.
52. Mackowiak, E.D., O'Connor, T.W., Geller, H., Nguyen, J. and Wilkes, W. (1997), “A survey of pharmacists' and pharmacy students' attitudes toward OTC advertising”, Journal of Pharmaceutical Marketing & Management, Vol. 12 No. 1, pp. 33-49.
53. Martin, C.E. and Duncan, D.F. (1984), “Televised OTC drug ads as surrogate dope pushers among young people”, Journal of Alcohol and Drug Education, Vol. 25, Spring, pp. 19-30.
54. Milavsky, J.R., Pekowsky, B. and Stipp, H. (1975-1976), “TV drug advertising and proprietary and illicit drug use among teenage boys”, Public Opinion Quarterly, Vol. 39 No. 4, pp. 457-81.
55. Miley, M. (2009), “Consumers flock to private labels”, Advertising Age, 2 February, p. 27.
56. Mukherjee, A. and McGinnis, J. (2007), “E-healthcare: an analysis of key themes in research”, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3 No. 4, pp. 349-63.
57. Neff, J. (2009), “Pepto beats private-label despite 60% price premium”, Advertising Age, 21 September, pp. 3 and 49.
58. OTC Perspectives (2009), “Spending review: the latest spending data from Nielsen Monitor-Plus”, OTC Perspectives, Vol. 1 No. 1, p. 10.
59. Palumbo, F.B. and Mullins, D. (2002), “The development of direct to consumer prescription drug advertising regulation”, Food and Drug Law Journal, Vol. 57 No. 3, pp. 423-43.
60. Pew Internet and American Life Project (2008), “Internet activities”, available at: www.pewinternet.org/trends/Internet_Activities_7.22.08.htm (accessed 26 April 2010).
61. Pew Internet and American Life Project (2009), “Internet adoption”, available at: www.pewinternet.org/Trend-Data/Internet-Adoption.aspx (accessed 26 April 2010).
62. Pinto, M.B. and Gehrt, K. (1991), “The do-it-yourself health care consumer”, Health Marketing Quarterly, Vol. 8 Nos 3/4, pp. 97-106.
63. Portner, T.S. and Smith, M.C. (1994), “College students' perceptions of OTC information source characteristics”, Journal of Pharmaceutical Marketing & Management, Vol. 8 No. 1, pp. 161-85.
64. Rallapalli, K.C., Smith, M.C. and Stone, G.W. (1994), “The social portrayal of people in OTC drug advertising: a content analysis of magazine advertisements”, Journal of Pharmaceutical Marketing & Management, Vol. 8 No. 2, pp. 111-26.
65. Reisenwitz, T.H. and Wimbush, G.J. (1997), “The purchase decision process and involvement of the elderly regarding nonprescription drugs”, Health Marketing Quarterly, Vol. 15 No. 1, pp. 49-68.
66. Reynolds, W.J. (1992), “Trends in advertising pharmaceuticals: a publisher's perspective”, Journal of Pharmaceutical Marketing & Management, Vol. 7 No. 1, pp. 5-22.
67. Robertson, T.S., Rossiter, J.R. and Gleason, T.C. (1979), “Children's receptivity to proprietary medicine advertising”, Journal of Consumer Research, Vol. 6, pp. 247-55.
68. Rossano, M.J. and Butter, E.J. (1987), “Television advertising and children's attitudes toward proprietary medicines”, Psychology & Marketing, Vol. 4 No. 3, pp. 213-24.
69. Rossiter, J.R. and Robertson, T.S. (1980), “Children's dispositions toward proprietary drugs and the role of television advertising”, Public Opinion Quarterly, Vol. 44 No. 3, pp. 316-29.
70. Sansgiry, S., Sharp, W.T. and Sansgiry, S.S. (1999), “Accuracy of information on printed over-the-counter advertisements”, Health Marketing Quarterly, Vol. 17 No. 2, pp. 7-18.
71. Schwartz, V.E., Silverman, C., Hulka, M.J. and Appel, C.E. (2009), “Marketing pharmaceutical products in the twenty-first century: an analysis of the continued viability of traditional principles of law in the age of direct to consumer advertising”, Harvard Journal of Law and Public Policy, Vol. 32 No. 1, pp. 333-62.
72. Sheehan, K. (2007), “Direct-to-consumer (DTC) branded drug web sites”, Journal of Advertising, Vol. 36 No. 3, pp. 123-35.
73. Sheth, J.D. (1974), “Measurement of advertising effectiveness: some theoretical considerations”, Journal of Advertising, Vol. 3 No. 1, pp. 6-11.
74. Shimp, T.A. and Dyer, R.F. (1979), “The pain-pill-pleasure model and illicit drug consumption”, Journal of Consumer Research, Vol. 6, June, pp. 36-46.
75. Smith, M.C. (1983), Principles of Pharmaceutical Marketing, Lea & Febiger, Philadelphia, PA.
76. Soller, R.W. (1998), “Evolution of self-care and over-the-counter medication”, Clinical Therapeutics, Vol. 20, pp. C134-40 (Supplement C).
77. Soller, R.W. (2002), “Prescription-to-over-the-counter switch criteria”, Drug Information Journal, Vol. 36, pp. 309-17.
78. Stallings, S. (1992), “From printing press to pharmaceutical representative: a social history of drug advertising and promotion”, Journal of Drug Issues, Vol. 22 No. 2, pp. 205-19.
79. Stephens, E.C. and Johnson, M.S. (2000), “Dr. Mom and other influences on younger and older adults' OTC medication purchases”, Journal of Applied Gerontology, Vol. 19, December, pp. 441-59.
80. Sullivan, D.L., Birdwell, S.W. and Kucukarlan, S.N. (1994), “An assessment of consumer purchasing behavior for private-label vs. brand-name over-the-counter products in chain pharmacies”, Journal of Pharmaceutical Marketing & Management, Vol. 8 No. 1, pp. 85-108.
81. Taylor, C.R., Capella, M.L. and Kozup, J.C. (2007), “Does DTC advertising provide information or create market power? Evidence from the US and New Zealand”, Advances in International Marketing, Vol. 18, pp. 9-30.
82. Tsao, J.C. (1997), “Informational and symbolic content of over-the-counter drug advertising on television”, Journal of Drug Education, Vol. 27 No. 2, pp. 173-97.
83. Vener, A.M. and Krupka, L.R. (1986), “Over-the-counter drug advertising in gender oriented popular magazines”, Journal of Drug Education, Vol. 16 No. 4, pp. 367-81.
84. Watts, M.R. and Wilkenfeld, J.D. (1992), “The role of the Federal Trade Commission in regulating non-prescription drug advertising and promotion”, Journal of Drug Issues, Vol. 22, pp. 265-76.
85. Wilkes, M.S., Bell, R.A. and Kravitz, R.L. (2000), “Direct-to-consumer prescription drug advertising: trends, impact, and implications”, Health Affairs, Vol. 19 No. 2, pp. 110-28.
86. Wright, P. (1979), “Concrete action plans in TV messages to increase reading of drug warnings”, Journal of Consumer Research, Vol. 6, December, pp. 256-69.
87. Drug Week (2010), “OTC pharmaceuticals market report 2010”, Drug Week, 2 April.